Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems
January 18, 2024 09:00 ET
|
Sharps Technology Inc
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class...
Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement
September 29, 2023 09:54 ET
|
Sharps Technology Inc
Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement
Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals
September 28, 2023 10:52 ET
|
Sharps Technology Inc
Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facil
UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
September 27, 2023 12:03 ET
|
Sharps Technology Inc
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering...
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
September 27, 2023 09:14 ET
|
Sharps Technology Inc
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals
September 26, 2023 08:30 ET
|
Sharps Technology Inc
Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ for $50M and 10-Year Purchase Agreement for Over $400 Million from Nephron
Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales
July 12, 2023 08:33 ET
|
Sharps Technology Inc
Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the...
Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article
July 06, 2023 07:50 ET
|
Sharps Technology Inc
Company advances commercialization of Securegard smart safety syringe product linethrough qualification programs with a major medical device company Production of prefilled syringe products will...
Sharps Technology Issues Update Letter to Shareholders from CEO Robert Hayes
April 04, 2023 08:00 ET
|
Sharps Technology Inc
Commercial revenue from specialty safety syringe systems is advancing Company to launch its vial draw syringe systems in Q2 2023Launch of high-value, next-generation polymer-based products expected in...
Sharps Technology Appoints Justin Page as Vice President of Technical Operations
February 09, 2023 09:21 ET
|
Sharps Technology Inc
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...